Viewing Study NCT04566692


Ignite Creation Date: 2025-12-24 @ 3:37 PM
Ignite Modification Date: 2025-12-30 @ 5:24 AM
Study NCT ID: NCT04566692
Status: COMPLETED
Last Update Posted: 2023-09-29
First Post: 2020-09-22
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency
Sponsor: Grifols Therapeutics LLC
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-11-24
Start Date Type: ACTUAL
Primary Completion Date: 2022-07-18
Primary Completion Date Type: ACTUAL
Completion Date: 2022-07-25
Completion Date Type: ACTUAL
First Submit Date: 2020-09-22
First Submit QC Date: None
Study First Post Date: 2020-09-28
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-07-14
Results First Submit QC Date: None
Results First Post Date: 2023-08-07
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-09-13
Last Update Post Date: 2023-09-29
Last Update Post Date Type: ACTUAL